insights_auto
Outlook: 55.3% bullish·0.0% bearish
Go to analysischevron_right
INCY:NASDAQ
Incyte Corp
$118.81
arrow_downward
-1.02%(-1.23) 1D
Nov 3, 11:24:43 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$118.96
High
$121.26
Low
$118.58
Mkt. cap
24.22B
Avg. vol.
1.83M
Volume
517.43K
P/E ratio
63.18
52-wk high
$132.58
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
Open
$118.96
High
$121.26
Low
$118.58
Mkt. cap
24.22B
Avg. vol.
1.83M
Volume
517.43K
P/E ratio
63.18
52-wk high
$132.58
52-wk low
$89.25
EPS
$1.88
Beta
0.78
Shares outstanding
203.83M
No. of employees
3K
News stories
From web sources and news partners
GuruFocus
·
20 hours ago
INCY Maintained by Bernstein -- Price Target Raised to $108.00
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com